Next Article in Journal
A Review of the Clinical Progress of CT1812, a Novel Sigma-2 Receptor Antagonist for the Treatment of Alzheimer’s Disease
Previous Article in Journal
Unlocking the Neuroprotective Effect of Quercetin Against Cadmium-Induced Hippocampal Damage in Rats: PPARγ Activation as a Key Mechanism
 
 
Article

Article Versions Notes

Pharmaceuticals 2025, 18(5), 658; https://doi.org/10.3390/ph18050658
Action Date Notes Link
article pdf uploaded. 29 April 2025 18:36 CEST Version of Record https://www.mdpi.com/1424-8247/18/5/658/pdf-vor
article xml file uploaded 6 May 2025 08:48 CEST Original file -
article xml uploaded. 6 May 2025 08:48 CEST Update -
article pdf uploaded. 6 May 2025 08:48 CEST Updated version of record https://www.mdpi.com/1424-8247/18/5/658/pdf-vor
article html file updated 6 May 2025 08:52 CEST Original file -
article xml file uploaded 7 May 2025 08:34 CEST Update -
article xml uploaded. 7 May 2025 08:34 CEST Update https://www.mdpi.com/1424-8247/18/5/658/xml
article pdf uploaded. 7 May 2025 08:34 CEST Updated version of record https://www.mdpi.com/1424-8247/18/5/658/pdf
article html file updated 7 May 2025 08:37 CEST Update https://www.mdpi.com/1424-8247/18/5/658/html
Back to TopTop